Founded in 1995, Mountain View Pharmaceuticals is a biotechnology company in the biopharmaceutical drug delivery field. The company seeks to improve drugs through the application of its polymer coupling technology platforms and advanced analytical methods. Mountain View Pharmaceuticals has expertise in the areas of pharmaceutical development, protein biochemistry, immunology and polymer chemistry. MVP's technology platforms offer a number of benefits, including a reduction in the degradation and clearance rates of drugs and extension of their half-life, a reduction in the immunogenicity of drugs and the prevention of antibody attack and allergic responses, more favorable biodistribution of drugs and uptake by tumor or target tissue, improved solubility and stability and retained activity in drugs for a higher effective yield and increased potency in vivo. Mountain View Pharmaceuticals is headquartered in Menlo Park, Calif.